Catalent Dividend yield

 Price  110.90
 Dividend  0.00
 Earnings  3.48
 Cash-flow  2.42
 Book value  21.75
 Equity  19.02

Catalent is part of Food and Drug Retailers business, which is part of Consumer Services industry. Catalent is a company from USA, and his stocks are publicly traded.

Catalent paid a total dividend of 0 million USD last year, for a market value of 19,851 millions (Market Cap 18,824 millions). Dividend per share of Catalent is 0.00 USD, and his stock market price 110.90 USD.

According to the chart below where dividend yield is displayed, Catalent, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from USA, Consumer Services industry, and Food and Drug Retailers sector. This lack of dividends of Catalent might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Catalent dividend yield with other Food and Drug Retailers companies or firms from USA.

Dividend yield of Catalent

Catalent Dividend Payout

About the ability of Catalent to maintain his current dividend of USD 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Catalent payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Catalent, compared againt world market average, USA companies, Consumer Services industry and Food and Drug Retailers sector companies.

Catalent payout

Catalent Dividend History

Year Yield  USD  Paypout  Shares* 

*In millions

Catalent Stock performance

Finally, last moth Catalent showed a return of 8.70% compared to a worldwide 1.12% average, and a 0.56% of Consumer Services firms. Over the last year, the company obtained a 5.30% versus a worldwide performance of a 5.73%. More detailed information can be seen in the following graph for USA and Food and Drug Retailers firms.

Catalent stock and market return